The immunologic aspects of poxvirus oncolytic therapy

被引:28
|
作者
Worschech, Andrea [1 ,2 ,3 ,4 ]
Haddad, D. [1 ,4 ,5 ]
Stroncek, D. F. [6 ]
Wang, E. [2 ,3 ]
Marincola, Francesco M. [2 ,3 ]
Szalay, Aladar A. [1 ,4 ]
机构
[1] Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA
[2] NIH, CHI, Ctr Clin, Bethesda, MD 20892 USA
[3] NIH, IDIS, Dept Transfus Med, Bethesda, MD 20892 USA
[4] Univ Wurzburg, Inst Biochem, Virchow Ctr Expt Biomed, Wurzburg, Germany
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[6] NIH, Cell Therapy Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA
关键词
Vaccinia virus; Oncolytic therapy; Innate immunity; Tumor rejection; NATURAL-KILLER-CELLS; VACCINIA-VIRUS; INTERFERON-GAMMA; IMMUNE-RESPONSE; INNATE IMMUNITY; T-CELLS; SPECIES-SPECIFICITY; ANTITUMOR IMMUNITY; CANCER-THERAPY; TUMOR-CELLS;
D O I
10.1007/s00262-009-0686-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The concept of using replicating oncolytic viruses in cancer therapy dates to the beginning of the twentieth century. However, in the last few years, an increasing number of pre-clinical and clinical trials have been carried out with promising preliminarily results. Novel, indeed, is the suggestion that viral oncolytic therapy might not operate exclusively through an oncolysis-mediated process but additionally requires the "assistance" of the host's immune system. Originally, the host's immune response was believed to play a predominant obstructive role against viral replication, hence limiting the anti-tumor efficacy of viral vectors. Recent data, however, suggest that the immune response may also play a key role in promoting tumor destruction in association with the oncolytic process. In fact, immune effector pathways activated during oncolytic virus-induced tumor rejection seem to follow a similar pattern to those observed when the broader phenomenon of immune-mediated tissue-specific rejection occurs in other immune-related pathologies. We recently formulated the "Immunologic Constant of Rejection" hypothesis, emphasizing commonalties in transcriptional patterns observed when tissue-destruction occurs: whether with a favorable outcome, such as in tumor rejection and pathogen clearance; or a destructive one, such as in allograft rejection or autoimmunity. Here, we propose that a similar mechanism induces clearance of virally infected tumors and that such a mechanism is primarily dependent on innate immune functions.
引用
收藏
页码:1355 / 1362
页数:8
相关论文
共 50 条
  • [21] IMMUNOLOGIC ASPECTS OF CANCER
    SOPHOCLES, AM
    NADLER, SH
    SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY, 1971, 133 (02): : 321 - +
  • [22] IMMUNOLOGIC ASPECTS OF PLASMINOGEN
    SACHS, V
    SZIRMAI, E
    ANGIOLOGY, 1970, 21 (01) : 1 - &
  • [23] IMMUNOLOGIC ASPECTS OF INFERTILITY
    BEHRMAN, SJ
    INTERNATIONAL JOURNAL OF FERTILITY, 1961, 6 (04) : 349 - +
  • [24] IMMUNOLOGIC ASPECTS OF PINTA
    GONCALVES, AP
    DERMATOLOGICA, 1967, 135 (02): : 199 - +
  • [25] Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
    Zeh, HJ
    Bartlett, DL
    CANCER GENE THERAPY, 2002, 9 (12) : 1001 - 1012
  • [26] Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
    Herbert J Zeh
    David L Bartlett
    Cancer Gene Therapy, 2002, 9 : 1001 - 1012
  • [27] Immunologic Mechanisms and Clinical Research Progress of Oncolytic Viruses
    Yang Hao
    Zhang Shao-Geng
    Yang Peng-Hui
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (08) : 1398 - 1405
  • [28] Enhancing poxvirus oncolytic effects through increased spread and immune evasion
    Kirn, David H.
    Wang, Yaohe
    Liang, Wenchung
    Contag, Christopher H.
    Thorne, Stephen H.
    CANCER RESEARCH, 2008, 68 (07) : 2071 - 2075
  • [29] Gene therapy with poxvirus vectors
    Moroziewicz, D
    Kaufman, HL
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (04) : 317 - 325
  • [30] Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma
    Baril, Patrick
    Touchefeu, Yann
    Cany, Jeannette
    Cherel, Yan
    Thorne, Steve H.
    Tran, Lucile
    Conchon, Sophie
    Vassaux, Georges
    JOURNAL OF GENE MEDICINE, 2011, 13 (12): : 692 - 701